actoprotective activity of 5-(2-bromophenyl)-4-amino-4h-1,2,4-triazole-3-thione and its s-derivatives
Clicks: 319
ID: 207076
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
71.9
/100
319 views
256 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Aim. The paper shows the actoprotective (anti-fatigue), activity of 1,2,4-triazole derivatives.
Methods and results. The analysis of action was conducted for the synthesized 2-(5-(2-bromphenyl)-4-amino-4H-1,2,4-triazol-3-ylthio) acetic acid salts. We have revealed some patterns regarding to the chemical structure and pharmacological action of the test substances.
Thus, in the research we have found that the most active compound among the studied was morpholinium 2-(5-(2-bromphenyl)-4-amino-4H-1,2,4-triazol-3-ylthio) acetate (3j), which increases the duration of rats (forced swimming with the load) as compared with the control group at 77,17% (pĖ0,05), while the reference drug increases the rate at 24,16% (pĖ0,05).
We have noted the compound 3i which exceed its activity comparing to Riboxinum at 23,2%, with increased endurance during the animals forced swimming test to 47,36% (pĖ0,05).
Conclusions. It is marked that the parent thione 1a and its derivative of 2-(5-(2-bromophenyl)-4-amino-4H-1,2,4-triazol-3-ylthio) acetic acid salt 2a and 3d, 3e, 3f have no actoprotective properties in their application.
After analyzing the data of experimental studies some laws concerning the chemical structure and pharmacological action of the test substance have been established.
Reference Key |
pruglo2016aktualnactoprotective
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | ;Ye. S. Pruglo |
Journal | current opinion in structural biology |
Year | 2016 |
DOI |
10.14739/2409-2932.2016.1.61438
|
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.